Published Guidance, NICE advice and quality standards
Showing 61 to 68 of 68
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Schizophrenia: lurasidone | ESNM48 | ||
| Schizophrenia: omega-3 fatty acid medicines | ESUOM19 | ||
| Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide | ES5 | ||
| Skin involvement in systemic sclerosis: rituximab | ES7 | ||
| Symptoms of peripheral arterial disease: ramipril | ESUOM45 | ||
| Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) | ESNM65 | ||
| Type 2 diabetes: insulin degludec | ESNM25 | ||
| Type 2 diabetes: insulin degludec/liraglutide (Xultophy) | ESNM60 |